[{"data":1,"prerenderedAt":325},["ShallowReactive",2],{"journal-sante-2026-09-24":3},{"sujets":4,"jours":49,"contexte":312,"editeursDuJour":313,"publicationsDuJour":314,"themesDuJour":315,"regionsDuJour":321,"nbSujetsRubrique":324},[5,19,30,39],{"id":6,"rubrique":7,"titre":8,"resume":9,"date":10,"nbSources":11,"articles":12,"amorce":17,"attribution":18},"sante-subventions-6c91b86a8d22b29f","sante","Assurance maladie obligatoire et complémentaires santé : un éclairage chiffré sur les scénarios d'évolution du financement des soins","Émilie Fauchier-Magnan (IGAS), Anouk Canet, Adrien Charlet (IGF) L'IGAS et l'IGF publient une étude de chiffrage destinée à éclairer les débats sur l'avenir de l'articulation entre assurance maladie obligatoire et complémentaires santé.","2026-09-24",1,[13],{"titre":8,"editeur":14,"url":15,"date":10,"publieLe":16},"Igas — Rapports et actualités","https:\u002F\u002Figas.gouv.fr\u002Fassurance-maladie-obligatoire-et-complementaires-sante-un-eclairage-chiffre-sur-les-scenarios-devolution-du-financement-des-soins","2026-09-24T13:04:20.000Z","Émilie Fauchier-Magnan (IGAS), Anouk Canet, Adrien Charlet (IGF) L'IGAS et l'IGF publient une étude de chiffrage destinée à éclairer les…","Texte officiel reproduit — Inspection générale des affaires sociales, Licence Ouverte \u002F Etalab 2.0",{"id":20,"rubrique":7,"titre":21,"resume":22,"date":10,"nbSources":11,"articles":23,"amorce":28,"attribution":29},"sante-reglementation-3b353ca1def83975","ZEPZELCA (lurbinectédine) - Cancer bronchique à petites cellules de stade étendu","Autorisation d’accès précoce refusée à la spécialité ZEPZELCA (lurbinectédine) dans l'indication « ZEPZELCA, en association avec l'atézolizumab, est indiqué dans le traitement d'entretien des patients adultes atteints d'un cancer du poumon à petites cellules de stade étendu (CPPC-SE), sans métastases du SNC, dont la maladie n'a pas progressé après un traitement d’induction de première intention par atézolizumab, carboplatine et étoposide.",[24],{"titre":21,"editeur":25,"url":26,"date":10,"publieLe":27},"HAS — Décisions sur les accès précoces","https:\u002F\u002Fwww.has-sante.fr\u002Fjcms\u002Fp_4487229\u002Ffr\u002Fzepzelca-lurbinectedine-cancer-bronchique-a-petites-cellules-de-stade-etendu","2026-09-24T09:12:51.000Z","Autorisation d’accès précoce refusée à la spécialité ZEPZELCA (lurbinectédine) dans l'indication « ZEPZELCA, en association avec…","Texte officiel reproduit — Haute Autorité de santé, Licence Ouverte \u002F Etalab 2.0",{"id":31,"rubrique":7,"titre":32,"resume":33,"date":10,"nbSources":11,"articles":34,"amorce":38,"attribution":29},"sante-reglementation-ca86f7e31748abde","KOSELUGO (sélumétinib) - Neurofibromatose de type 1 (NF1)","Autorisation d’accès précoce renouvelée à la spécialité KOSELUGO (sélumétinib) dans l'indication « En monothérapie dans le traitement des neurofibromes plexiformes (NFP) symptomatiques inopérables liés à une neurofibromatose de type 1 (NF1) chez les patients adultes ». Ce médicament a une AMM dans cette indication et fait toujours l'objet",[35],{"titre":32,"editeur":25,"url":36,"date":10,"publieLe":37},"https:\u002F\u002Fwww.has-sante.fr\u002Fjcms\u002Fp_4487262\u002Ffr\u002Fkoselugo-selumetinib-neurofibromatose-de-type-1-nf1","2026-09-24T09:31:48.000Z","Autorisation d’accès précoce renouvelée à la spécialité KOSELUGO (sélumétinib) dans l'indication « En monothérapie dans le traitement des…",{"id":40,"rubrique":7,"titre":41,"resume":42,"date":10,"nbSources":11,"articles":43,"amorce":48,"attribution":29},"sante-reglementation-ae4cf7bf626db179","Bonnes pratiques de simulation en santé pour la formation à la relation professionnel-patient","La qualité de la relation entre les professionnels de santé, les patients et leurs proches est un élément essentiel de la qualité et de la sécurité des soins. Le développement des compétences relationnelles, communicationnelles, émotionnelles et réflexives constitue un enjeu de formation tout au long du parcours professionnel.",[44],{"titre":41,"editeur":45,"url":46,"date":10,"publieLe":47},"HAS — Actualité","https:\u002F\u002Fwww.has-sante.fr\u002Fjcms\u002Fp_4487188\u002Ffr\u002Fbonnes-pratiques-de-simulation-en-sante-pour-la-formation-a-la-relation-professionnel-patient","2026-09-24T07:54:55.000Z","La qualité de la relation entre les professionnels de santé, les patients et leurs proches est un élément essentiel de la qualité et de la…",[50,51,52,53,54,55,10,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311],"2026-10-02","2026-10-01","2026-09-30","2026-09-29","2026-09-28","2026-09-25","2026-09-23","2026-09-22","2026-09-21","2026-09-18","2026-09-16","2026-09-15","2026-09-14","2026-09-11","2026-09-10","2026-09-09","2026-09-07","2026-09-04","2026-09-02","2026-08-31","2026-08-28","2026-08-26","2026-08-25","2026-08-24","2026-08-21","2026-08-20","2026-08-19","2026-08-18","2026-08-17","2026-08-16","2026-08-14","2026-08-12","2026-08-11","2026-08-10","2026-08-05","2026-08-04","2026-08-03","2026-07-31","2026-07-30","2026-07-29","2026-07-27","2026-07-24","2026-07-23","2026-07-22","2026-07-21","2026-07-20","2026-07-17","2026-07-16","2026-07-15","2026-07-12","2026-07-10","2026-07-09","2026-07-06","2026-07-03","2026-07-02","2026-07-01","2026-06-30","2026-06-29","2026-06-26","2026-06-25","2026-06-24","2026-06-22","2026-06-19","2026-06-18","2026-06-17","2026-06-16","2026-06-12","2026-06-11","2026-06-10","2026-06-09","2026-06-08","2026-06-05","2026-06-02","2026-06-01","2026-05-29","2026-05-28","2026-05-27","2026-05-26","2026-05-22","2026-05-21","2026-05-19","2026-05-18","2026-05-13","2026-05-07","2026-05-05","2026-04-30","2026-04-24","2026-04-10","2026-04-09","2026-03-31","2026-03-26","2026-03-25","2026-03-24","2026-03-19","2026-03-16","2026-03-12","2026-03-10","2026-03-03","2026-03-02","2026-02-27","2026-02-26","2026-02-20","2026-02-19","2026-02-16","2026-02-11","2026-02-10","2026-02-09","2026-02-05","2026-02-02","2026-01-30","2026-01-27","2026-01-26","2026-01-22","2026-01-21","2026-01-20","2026-01-16","2026-01-12","2026-01-09","2025-12-31","2025-12-30","2025-12-29","2025-12-24","2025-12-22","2025-12-18","2025-12-17","2025-12-15","2025-12-09","2025-12-03","2025-12-01","2025-11-20","2025-11-17","2025-11-13","2025-11-05","2025-11-04","2025-10-24","2025-10-23","2025-10-22","2025-10-17","2025-10-16","2025-10-15","2025-10-14","2025-10-12","2025-10-11","2025-10-09","2025-10-04","2025-10-02","2025-10-01","2025-09-26","2025-09-25","2025-09-23","2025-09-22","2025-09-19","2025-09-17","2025-09-16","2025-09-15","2025-09-09","2025-09-06","2025-09-01","2025-08-27","2025-08-22","2025-08-20","2025-08-12","2025-08-01","2025-07-23","2025-07-21","2025-07-17","2025-07-16","2025-07-09","2025-07-08","2025-07-04","2025-07-02","2025-07-01","2025-06-30","2025-06-29","2025-06-24","2025-06-23","2025-06-21","2025-06-18","2025-06-17","2025-06-16","2025-06-13","2025-06-12","2025-06-11","2025-06-10","2025-05-28","2025-05-27","2025-05-25","2025-05-20","2025-05-14","2025-05-07","2025-04-30","2025-04-24","2025-04-18","2025-04-11","2025-04-09","2025-04-08","2025-04-04","2025-04-01","2025-03-27","2025-03-24","2025-03-21","2025-03-20","2025-03-17","2025-03-07","2025-03-05","2025-02-26","2025-02-24","2025-02-14","2025-02-11","2025-02-06","2025-02-04","2025-01-30","2025-01-24","2025-01-15","2025-01-13","2025-01-10","2025-01-09","2025-01-08","2025-01-06","2024-12-31","2024-12-30","2024-12-24","2024-12-20","2024-12-19","2024-12-18","2024-12-16","2024-12-13","2024-12-12","2024-12-10","2024-12-03","2024-11-29","2024-11-28","2024-11-26","2024-11-25","2024-11-22","2024-11-20","2024-11-19","2024-11-18","2024-11-14","2024-11-08","2024-11-07","2024-11-04","2024-10-31","2024-10-28","2024-10-24","2024-10-17","2024-10-16","2024-10-15","2024-10-14","2024-10-07","2024-10-04","2024-10-02","2024-10-01","2024-09-27","2024-09-25","2024-09-24","2024-09-23","2024-09-20","2024-09-19","2024-09-12","2024-09-04","2024-08-13","4 sujets ont été ouverts ce jour-là dans la rubrique Santé, à partir de 4 publications référencées émanant de 3 éditeurs distincts. Rapporté à la moyenne de la rubrique — 1,8 sujets par journée active sur 263 journées archivées — la journée est plus fournie que d'ordinaire, au rang 21 sur 263 par le volume (record de la rubrique : 8 sujets). La couverture du jour porte sur 2 sous-thèmes : Réglementation (3), Aides et subventions (1). 4 sujets du jour sont nationaux : aucun n'est rattaché à une région en particulier. Le sujet le plus repris de la journée compte 1 source distinctes ; le compteur mesure le nombre d'éditeurs ayant publié sur le même événement, pas le nombre d'articles. Cette page est la 257e journée archivée de la rubrique depuis l'ouverture du fil. Une journée sans sujet ne produit aucune page : l'archive ne contient donc jamais de jour vide.",[45,25,14],4,[316,319],{"slug":317,"nb":318},"reglementation",3,{"slug":320,"nb":11},"subventions",[322],{"slug":323,"nb":314},null,480,1791137639523]